Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05919342 · ClinicalTrials.gov registry record · NA
Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"
A NA study of Heart Failure and Cardiovascular Diseases, sponsored by NHS Greater Glasgow and Clyde.
- Recruiting
- Registry status
- NA
- Development phase
- 3,904
- Enrollment target
- 7
- Study locations
NCT05919342 is a NA study of Heart Failure and Cardiovascular Diseases that is actively recruiting participants, run by NHS Greater Glasgow and Clyde. The registered enrollment target is 3,904 participants, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (91% higher). The trial reports 7 study locations across 5 states.
The verdict
NCT05919342, a NA study of Heart Failure and Cardiovascular Diseases, is actively recruiting participants, sponsored by NHS Greater Glasgow and Clyde.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,904 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is an international prospective, multicentre, unblinded, randomised-controlled trial. The primary aim is to assess a targeted screening strategy to detect undiagnosed heart failure in high-risk patients.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST NT-proBNP
Study Locations (7)
Other
- Rigshospitalet, Copenhagen University Hospital - Copenhagen
- Karolinska University Hospital - Stockholm
- Uppsala University - Uppsala
Ohio
- Cleveland Clinic - Cleveland
British Columbia
- University of British Columbia - Vancouver
Quebec
- University of Montreal - Montreal
Scotland
- University of Glasgow - Glasgow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,904 participants |
| Start Date | 2022-12-22 |
| Est. Completion | 2032-12-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05919342
The ClinicalTrials.gov registry entry for NCT05919342 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,904 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,039-participant average among 397 other Heart Failure trials with a reported enrollment target (91% higher). The listed sponsor is NHS Greater Glasgow and Clyde, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which NT-proBNP is the first listed.
NCT05919342 reports 7 study locations spanning 5 distinct geographic areas - top geographies include Other, Ohio, British Columbia.
Frequently Asked Questions
What is clinical trial NCT05919342 about?
NCT05919342 is a clinical study titled "Screening for earlY Heart Failure Diagnosis and Management in Primary Care or at HOme Using Natriuretic Peptides and echocardiographY "SYMPHONY-HF"". This is an international prospective, multicentre, unblinded, randomised-controlled trial. The primary aim is to assess a targeted screening strategy to detect undiagnosed heart failure in high-risk patients.
What is the current status of trial NCT05919342?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,904 participants. The study started on 2022-12-22. Estimated completion is 2032-12-21.
What conditions does trial NCT05919342 study?
This clinical trial studies the following conditions: Heart Failure, Cardiovascular Diseases.
What interventions are being tested in trial NCT05919342?
The interventions under investigation include: NT-proBNP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05919342?
This trial is sponsored by NHS Greater Glasgow and Clyde, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05919342 being conducted?
This trial has 7 study locations across Ohio, British Columbia, Quebec, Scotland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.